TEJALBEN PATEL: Open Payments
NPI 1972998839 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 14 payments from 8 companies in 2025. Trend: 2023 $481 · 2024 $380 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $92 |
| Tanabe Pharma America, Inc. | 2 | $47 |
| Biogen, Inc. | 2 | $47 |
| SK Life Science, Inc. | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Zilbrysq, Radicava, SKYCLARYS, AMVUTTRA, Rystiggo, AUSTEDO XR, WAINUA.
Industry payments across GA — which companies pay providers there.
